Adaptimmune Therapeutics plc(ADAP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ADAP Adaptimmune Therapeutics plc

交易中 09-10 09:38:25 EDT

0.0549

+0.0000

0.00%

最高0.0549	最低0.0549	成交量0.00
今开0.0549	昨收0.0549	日振幅0.00%
总市值1,455万	流通市值1,005万	总股本2.65亿
成交额0.00	换手率0.00%	流通股本1.83亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ADAP","market":"US","secType":"STK","nameCN":"Adaptimmune Therapeutics plc","latestPrice":0.0549,"timestamp":1764018000000,"preClose":0.0549,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":183084412,"shares":265051591,"eps":-0.657397,"marketStatus":"交易中","change":0,"latestTime":"09-10 09:38:25 EDT","open":0.0549,"high":0.0549,"low":0.0549,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.657397,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1789070400000},"marketStatusCode":2,"adr":1,"adrRate":6,"listingDate":1430884800000,"exchange":"NASDAQ","adjPreClose":0.0549,"volumeRatio":0},"requestUrl":"/m/hq/s/ADAP","defaultTab":"news","newsList":[{"id":"2518027975","title":"Adaptimmune Therapeutics Plc盘中异动 快速下挫5.12%报0.455美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518027975","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518027975?lang=zh_cn&edition=full","pubTime":"2025-03-10 23:11","pubTimestamp":1741619463,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日23时11分，Adaptimmune Therapeutics Plc股票出现波动，股价急速跳水5.12%。截至发稿，该股报0.455美元/股，成交量33.2454万股，换手率0.13%，振幅6.19%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.76%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Protagonist Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Aeon Biopharma, Inc.、Scisparc Ltd.较为活跃，换手率分别为3561.12%、944.59%、796.47%，振幅较大的相关个股有Scisparc Ltd.、Aeon Biopharma, Inc.、Dogwood Therapeutics, Inc.，振幅分别为49.87%、41.96%、41.36%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310231103abf320f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310231103abf320f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ADAP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517620071","title":"Adaptimmune Therapeutics Plc盘中异动 快速跳水5.01%报0.481美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517620071","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517620071?lang=zh_cn&edition=full","pubTime":"2025-03-07 00:01","pubTimestamp":1741276867,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日00时01分，Adaptimmune Therapeutics Plc股票出现异动，股价快速下挫5.01%。截至发稿，该股报0.481美元/股，成交量19.1667万股，换手率0.07%，振幅6.93%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体跌幅为0.47%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000108989ec595&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000108989ec595&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ADAP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516630868","title":"Adaptimmune Therapeutics Plc盘中异动 股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516630868","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516630868?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:21","pubTimestamp":1741015310,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时21分，Adaptimmune Therapeutics Plc股票出现波动，股价大幅下跌5.11%。截至发稿，该股报0.512美元/股，成交量21.6999万股，换手率0.08%，振幅8.52%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体跌幅为0.23%。其相关个股中，Bioxcel Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Aldeyra Therapeutics, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为1780.98%、134.75%、117.36%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Pliant Therapeutics, Inc.，振幅分别为177.97%、70.53%、48.34%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303232150abe64392&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303232150abe64392&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADAP","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516330316","title":"Adaptimmune Therapeutics Plc盘中异动 下午盘股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516330316","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516330316?lang=zh_cn&edition=full","pubTime":"2025-03-01 03:14","pubTimestamp":1740770093,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日03时14分，Adaptimmune Therapeutics Plc股票出现异动，股价快速下挫5.10%。截至发稿，该股报0.523美元/股，成交量57.6599万股，换手率0.23%，振幅8.17%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.16%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301031454abe129ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301031454abe129ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ADAP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514336413","title":"Adaptimmune Therapeutics Plc盘中异动 股价大跌5.16%报0.557美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514336413","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514336413?lang=zh_cn&edition=full","pubTime":"2025-02-28 01:26","pubTimestamp":1740677217,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日01时26分，Adaptimmune Therapeutics Plc股票出现异动，股价急速跳水5.16%。截至发稿，该股报0.557美元/股，成交量58.8597万股，换手率0.23%，振幅7.56%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.39%。其相关个股中，Cingulate Inc C/Wts 10/12/2026 、Ibio, Inc.、Pepgen Inc.涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为1722.67%、296.54%、125.38%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pds Biotechnology Corporation、Quoin Pharmaceuticals Ltd，振幅分别为86.14%、50.65%、47.79%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228012657abdf9765&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228012657abdf9765&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ADAP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514043500","title":"Adaptimmune Therapeutics Plc盘中异动 股价大涨5.02%报0.580美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514043500","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514043500?lang=zh_cn&edition=full","pubTime":"2025-02-26 02:42","pubTimestamp":1740508974,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日02时42分，Adaptimmune Therapeutics Plc股票出现波动，股价大幅拉升5.02%。截至发稿，该股报0.580美元/股，成交量140.456万股，换手率0.55%，振幅9.87%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.17%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226024254abdcb9a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226024254abdcb9a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ADAP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512611501","title":"Adaptimmune Therapeutics Plc盘中异动 早盘股价大涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512611501","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512611501?lang=zh_cn&edition=full","pubTime":"2025-02-18 23:33","pubTimestamp":1739892797,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日23时33分，Adaptimmune Therapeutics Plc股票出现波动，股价大幅上涨5.26%。截至发稿，该股报0.608美元/股，成交量28.6003万股，换手率0.11%，振幅3.72%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.61%。其相关个股中，Estrella Immunopharma Inc C/Wts 29/09/2028、Abvc Biopharma, Inc.、Allogene Therapeutics, Inc.涨幅较大，Aditxt, Inc.、Moleculin Biotech, Inc.、Solid Biosciences Inc.较为活跃，换手率分别为365.34%、160.89%、138.02%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Abvc Biopharma, Inc.、Allogene Therapeutics, Inc.，振幅分别为148.75%、89.24%、79.17%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218233317988a0939&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218233317988a0939&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADAP","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510033345","title":"Adaptimmune Therapeutics Plc盘中异动 股价大跌5.14%报0.570美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510033345","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510033345?lang=zh_cn&edition=full","pubTime":"2025-02-11 23:10","pubTimestamp":1739286636,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日23时10分，Adaptimmune Therapeutics Plc股票出现异动，股价大幅跳水5.14%。截至发稿，该股报0.570美元/股，成交量19.7939万股，换手率0.08%，振幅2.25%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体跌幅为1.56%。其相关个股中，Ocean Biomedical, Inc.、Lipella Pharmaceuticals Inc.、Dominari Holdings Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2516.84%、798.64%、334.03%，振幅较大的相关个股有Dominari Holdings Inc.、Ocean Biomedical, Inc.、In8Bio, Inc.，振幅分别为52.11%、43.92%、37.99%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211231036961f4f58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211231036961f4f58&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADAP","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510867556","title":"Adaptimmune Therapeutics Plc盘中异动 股价大跌5.26%报0.587美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510867556","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510867556?lang=zh_cn&edition=full","pubTime":"2025-02-11 00:16","pubTimestamp":1739204167,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日00时16分，Adaptimmune Therapeutics Plc股票出现异动，股价急速下挫5.26%。截至发稿，该股报0.587美元/股，成交量6.9522万股，换手率0.03%，振幅5.05%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.04%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211001608abc9bbd7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211001608abc9bbd7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ADAP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509778587","title":"Adaptimmune Therapeutics Plc盘中异动 下午盘股价大涨5.25%报0.618美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509778587","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509778587?lang=zh_cn&edition=full","pubTime":"2025-02-07 03:48","pubTimestamp":1738871322,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日03时48分，Adaptimmune Therapeutics Plc股票出现异动，股价快速拉升5.25%。截至发稿，该股报0.618美元/股，成交量70.2531万股，换手率0.27%，振幅5.95%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体跌幅为0.59%。其相关个股中，Lipella Pharmaceuticals Inc.、Geovax Labs Inc C/Wts 29/09/2025、Equillium, Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为6944.75%、1750.17%、181.69%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 ，振幅分别为125.58%、69.09%、64.30%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207034842987cbb79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207034842987cbb79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ADAP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508941039","title":"Adaptimmune Therapeutics Plc盘中异动 快速跳水5.57%报0.575美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508941039","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2508941039?lang=zh_cn&edition=full","pubTime":"2025-02-01 04:07","pubTimestamp":1738354044,"startTime":"0","endTime":"0","summary":"北京时间2025年02月01日04时07分，Adaptimmune Therapeutics Plc股票出现异动，股价大幅跳水5.57%。截至发稿，该股报0.575美元/股，成交量35.9888万股，换手率0.14%，振幅4.93%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.50%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502010407249615113e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502010407249615113e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ADAP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507081486","title":"Adaptimmune Therapeutics Plc盘中异动 临近收盘急速拉升6.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507081486","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2507081486?lang=zh_cn&edition=full","pubTime":"2025-01-31 05:00","pubTimestamp":1738270850,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日05时00分，Adaptimmune Therapeutics Plc股票出现异动，股价急速上涨6.23%。截至发稿，该股报0.619美元/股，成交量68.5486万股，换手率0.27%，振幅6.83%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Tectonic Therapeutic, Inc.、Dominari Holdings Inc.、Alterity Therapeutics Limited涨幅较大，Kazia Therapeutics Limited、Silexion Therapeutics Corp、Alterity Therapeutics Limited较为活跃，换手率分别为1850.10%、350.52%、260.57%，振幅较大的相关个股有Dominari Holdings Inc.、Cero Therapeutics Holdings, Inc.、Kazia Therapeutics Limited，振幅分别为70.55%、65.98%、65.94%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131050051a2349563&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131050051a2349563&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ADAP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506895734","title":"Adaptimmune Therapeutics Plc盘中异动 股价大涨5.18%报0.607美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506895734","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506895734?lang=zh_cn&edition=full","pubTime":"2025-01-25 01:32","pubTimestamp":1737739941,"startTime":"0","endTime":"0","summary":"北京时间2025年01月25日01时32分，Adaptimmune Therapeutics Plc股票出现波动，股价急速拉升5.18%。截至发稿，该股报0.607美元/股，成交量27.4101万股，换手率0.11%，振幅7.16%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Evaxion Biotech As、Pmgc Holdings Inc.、Celularity Inc C/Wts 16/07/2026 涨幅较大，Evaxion Biotech As、Pmgc Holdings Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为4062.88%、2268.76%、1654.35%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Evaxion Biotech As、Celularity Inc C/Wts 16/07/2026 ，振幅分别为134.08%、112.09%、69.09%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125013221abb775e1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125013221abb775e1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ADAP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505046378","title":"Adaptimmune Therapeutics Plc盘中异动 临近午盘急速下挫5.01%报0.546美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505046378","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505046378?lang=zh_cn&edition=full","pubTime":"2025-01-24 00:50","pubTimestamp":1737651003,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日00时50分，Adaptimmune Therapeutics Plc股票出现波动，股价急速下跌5.01%。截至发稿，该股报0.546美元/股，成交量19.5418万股，换手率0.08%，振幅4.19%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.51%。其相关个股中，Dogwood Therapeutics, Inc.、Nutriband Inc C/Wts 、Exicure, Inc.涨幅较大，Hepion Pharmaceuticals, Inc.、Dogwood Therapeutics, Inc.、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为3613.84%、2684.54%、667.19%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Nutriband Inc C/Wts 、Jupiter Neurosciences, Inc.，振幅分别为246.43%、65.78%、55.57%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124005003abb61743&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124005003abb61743&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ADAP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505277552","title":"Adaptimmune Therapeutics Plc盘中异动 早盘股价大跌5.14%报0.550美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505277552","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505277552?lang=zh_cn&edition=full","pubTime":"2025-01-21 23:06","pubTimestamp":1737472015,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日23时06分，Adaptimmune Therapeutics Plc股票出现异动，股价大幅跳水5.14%。截至发稿，该股报0.550美元/股，成交量13.477万股，换手率0.05%，振幅3.36%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为1.06%。其相关个股中，Channel Therapeutics Corporation、Dogwood Therapeutics, Inc.、Genelux Corporation涨幅较大，Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Dermata Therapeutics, Inc.较为活跃，换手率分别为683.50%、197.88%、170.65%，振幅较大的相关个股有阿诺医药、Channel Therapeutics Corporation、Dogwood Therapeutics, Inc.，振幅分别为103.41%、92.63%、38.48%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121230656abb34fa5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121230656abb34fa5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ADAP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504120559","title":"Adaptimmune Therapeutics Plc盘中异动 股价大跌5.73%报0.572美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504120559","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2504120559?lang=zh_cn&edition=full","pubTime":"2025-01-17 00:28","pubTimestamp":1737044930,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日00时28分，Adaptimmune Therapeutics Plc股票出现异动，股价急速下跌5.73%。截至发稿，该股报0.572美元/股，成交量27.9393万股，换手率0.11%，振幅3.56%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体跌幅为0.41%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117002850abad6a52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117002850abad6a52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ADAP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503296796","title":"Adaptimmune Therapeutics Plc盘中异动 股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503296796","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503296796?lang=zh_cn&edition=full","pubTime":"2025-01-15 23:41","pubTimestamp":1736955682,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日23时41分，Adaptimmune Therapeutics Plc股票出现波动，股价快速跳水5.07%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为1.12%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Lexaria Bioscience Corp C/Wts 14/01/2026 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Windtree Therapeutics, Inc.、Phio Pharmaceuticals Corp.、Os Therapies Incorporated较为活跃，换手率分别为206.38%、150.52%、79.59%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Os Therapies Incorporated，振幅分别为68.03%、61.60%、61.30%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011523412298674e4a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011523412298674e4a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADAP","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503358355","title":"Adaptimmune Therapeutics Plc盘中异动 急速下跌6.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503358355","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2503358355?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:35","pubTimestamp":1736778916,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时35分，Adaptimmune Therapeutics Plc股票出现波动，股价快速下跌6.06%。截至发稿，该股报0.582美元/股，成交量20.1823万股，换手率0.08%，振幅4.84%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体跌幅为1.06%。其相关个股中，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为3287.81%、2073.54%、392.45%，振幅较大的相关个股有Salarius Pharmaceuticals, Inc.、Champions Oncology, Inc.、Phio Pharmaceuticals Corp.，振幅分别为104.79%、102.87%、60.36%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223516960253bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223516960253bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ADAP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502281191","title":"Adaptimmune Therapeutics Plc盘中异动 下午盘大幅下跌6.31%报0.581美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502281191","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2502281191?lang=zh_cn&edition=full","pubTime":"2025-01-11 03:56","pubTimestamp":1736539011,"startTime":"0","endTime":"0","summary":"北京时间2025年01月11日03时56分，Adaptimmune Therapeutics Plc股票出现波动，股价大幅下挫6.31%。截至发稿，该股报0.581美元/股，成交量74.2542万股，换手率0.29%，振幅3.61%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体跌幅为2.16%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250111035652a21d53c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250111035652a21d53c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ADAP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501738555","title":"Adaptimmune Therapeutics Plc盘中异动 大幅下跌5.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501738555","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2501738555?lang=zh_cn&edition=full","pubTime":"2025-01-08 01:42","pubTimestamp":1736271767,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日01时42分，Adaptimmune Therapeutics Plc股票出现波动，股价急速跳水5.83%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为1.05%。其相关个股中，Hoth Therapeutics, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Celularity Inc C/Wts 16/07/2026 涨幅较大，Hoth Therapeutics, Inc.、Cero Therapeutics Holdings, Inc.、Immuneering Corporation较为活跃，换手率分别为5013.10%、405.49%、238.47%，振幅较大的相关个股有Hoth Therapeutics, Inc.、Cero Therapeutics Holdings, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为287.95%、131.21%、87.05%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108014248985e33e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108014248985e33e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADAP","BK4139","LENZ"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.adaptimmune.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0.1159},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0036},{"period":"1month","weight":-0.0138},{"period":"3month","weight":0.0334},{"period":"6month","weight":0.1512},{"period":"1year","weight":0.1723},{"period":"ytd","weight":0.118}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Adaptimmune Therapeutics Plc成立于2014年12月3日，是一家根据英格兰和威尔士法律注册成立的公众有限公司。该公司是一家临床阶段的生物制药公司，将于2024年过渡到商业阶段的细胞治疗公司。该公司专注于为癌症患者提供新型细胞疗法。公司第一个产品，afamitresgene autoleucel或“afami-cel”是滑膜肉瘤特有的，将是肉瘤产品专营的第一个产品。他们计划于2026年在美国商业推出的Lete-cel将是肉瘤专营权的第二个产品，将同时针对滑膜肉瘤和粘液样圆细胞脂肪肉瘤，显著扩大可治疗的患者群体。","yearOnYearQuotes":[{"month":1,"riseRate":0.7,"avgChangeRate":0.24176},{"month":2,"riseRate":0.3,"avgChangeRate":0.006803},{"month":3,"riseRate":0.4,"avgChangeRate":-0.056152},{"month":4,"riseRate":0.7,"avgChangeRate":0.101482},{"month":5,"riseRate":0.4,"avgChangeRate":0.154958},{"month":6,"riseRate":0.272727,"avgChangeRate":-0.053678},{"month":7,"riseRate":0.363636,"avgChangeRate":-0.072088},{"month":8,"riseRate":0.363636,"avgChangeRate":-0.043688},{"month":9,"riseRate":0.454545,"avgChangeRate":0.076796},{"month":10,"riseRate":0.090909,"avgChangeRate":-0.249842},{"month":11,"riseRate":0.363636,"avgChangeRate":0.050929},{"month":12,"riseRate":0.4,"avgChangeRate":0.005688}],"exchange":"NASDAQ","name":"Adaptimmune Therapeutics plc","nameEN":"Adaptimmune Therapeutics PLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Adaptimmune Therapeutics plc(ADAP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Adaptimmune Therapeutics plc(ADAP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Adaptimmune Therapeutics plc,ADAP,Adaptimmune Therapeutics plc股票,Adaptimmune Therapeutics plc股票老虎,Adaptimmune Therapeutics plc股票老虎国际,Adaptimmune Therapeutics plc行情,Adaptimmune Therapeutics plc股票行情,Adaptimmune Therapeutics plc股价,Adaptimmune Therapeutics plc股市,Adaptimmune Therapeutics plc股票价格,Adaptimmune Therapeutics plc股票交易,Adaptimmune Therapeutics plc股票购买,Adaptimmune Therapeutics plc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Adaptimmune Therapeutics plc(ADAP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Adaptimmune Therapeutics plc(ADAP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}